Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

World journal of gastroenterology - 14 Apr 2014

Luo Hui-Yan, Xu Rui-Hua

Abstract excerpt

Colorectal cancer (CRC) is one of the most common human malignant diseases and the second leading cause of cancer-related deaths worldwide. The treatment of advanced CRC has improved significantly in recent years. With the emergence of two targeted antibodies, cetuximab (Erbitux), an anti-epidermal growth factor receptor monoclonal antibody and bevacizumab (Avastin), a vascular endothelial growth factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Bevacizumab
Share to Cetuximab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Neovascularization, Pathologic

Share to Proto-Oncogene Proteins c-met

Share to PTEN Phosphohydrolase

Share to Receptor, IGF Type 1

Source

Open in PubMed Open full text

Identifiers

PMID: 24744578
DOI: 10.3748/wjg.v20.i14.3858
PMCID: PMC3983442

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.PMID 24744578Read ↗

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.Semantic proximity Read ↗

Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Semantic proximity Read ↗

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.Semantic proximity Read ↗

Prognostic and predictive molecular biomarkers in advanced colorectal cancer.Semantic proximity Read ↗

Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work.Semantic proximity Read ↗

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and ChallengesSemantic proximity Read ↗

Prognostic biomarkers in colorectal cancer: where do we stand?Semantic proximity Read ↗

Prognostic and predictive biomarkers in nonmetastatic colorectal cancers.Semantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.Semantic proximity Read ↗

Current and future biomarkers in the treatment of colorectal cancerSemantic proximity Read ↗

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.